Abstract
Chronic restraint stress (CRS) is a well-established animal model for studying the physiological and psychological impacts of stress, including neuroinflammation and memory deficits. While fresh Gastrodia elata Blume (FG) has traditionally been used to treat headaches and neurodegenerative conditions, its specific impact on CRS-induced cognitive decline remains under-explored. This study evaluates the neuroprotective effects of FG through behavioral testing and biochemical analysis of mitochondrial apoptosis and inflammatory pathways in the mouse hippocampus.
Introduction
In modern society, chronic stress is a pervasive factor contributing to cognitive impairment. Research often utilizes the Chronic Restraint Stress (CRS) model to simulate these conditions, which typically results in systemic neuroinflammation and damage to the hippocampus—a brain region critical for memory. This study investigates whether fresh (unprocessed) Gastrodia elata Blume (FG) can mitigate these deficits.
Methods
The study utilized 120 ICR mice, subjected to 10 hours of daily restraint for 35 days. The mice were divided into control, CRS-model, and treatment groups (receiving Donepezil or varying doses of FG).
To ensure experimental consistency, the FG extract was standardized using Ultra-High-Performance Liquid Chromatography (UPLC). This process identified three primary active compounds: gastrodin, p-hydroxybenzyl alcohol, and parishin E.
Cognitive performance was assessed through a comprehensive behavioral battery:
- Spontaneous Behavior: Object Location Recognition Test (OLRT) and New Object Recognition Test (NORT).
- Spatial and Non-Spatial Memory: Morris Water Maze Test (MWMT) and Passive Avoidance Test (PAT).
Following behavioral trials, researchers analyzed hippocampal tissue using Western blots and ELISA to quantify protein expression related to the AKT/CREB pathway, mitochondrial fission (Drp1, Cyt C, BAX), and pro-inflammatory cytokines (TNF-α, IL-1β).
Key Insights and Results
The study yielded several significant findings regarding the neuroprotective mechanisms of FG:
1. Behavioral Improvement
FG treatment (1 g/kg) significantly enhanced cognitive performance. In recognition tests (OLRT and NORT), treated mice showed a higher Discrimination Index ($p < 0.05$). In the Morris Water Maze, FG significantly reduced escape latency by the fifth day of training ($p < 0.01$), indicating improved spatial memory.
2. Mitochondrial Protection and Anti-Apoptotic Effects
A critical discovery was FG’s ability to inhibit mitochondrial-mediated apoptosis. Stress typically triggers the activation of Drp1, leading to mitochondrial fragmentation and the release of Cytochrome C (Cyt C), which initiates cell death. FG treatment significantly suppressed these markers (Cyt C, Drp1, and BAX), effectively halting the "suicide signal" in hippocampal neurons.
3. Activation of the AKT/CREB Pathway
FG was found to promote the levels of phosphorylated (active) AKT and CREB. The CREB protein is vital for synaptic plasticity and neuronal regeneration. By activating this axis, FG does not merely prevent damage but supports the brain's inherent repair mechanisms.
4. Suppression of Neuroinflammation
Biochemical analysis confirmed that FG treatment led to a marked reduction in pro-inflammatory cytokines TNF-α and IL-1β in the hippocampus ($p < 0.05$ to $p < 0.001$), suggesting a potent anti-inflammatory effect.
Conclusion
The results suggest that fresh Gastrodia elata Blume effectively attenuates cognitive deficits induced by chronic stress. By targeting mitochondrial dysfunction, neuroinflammation, and the AKT/CREB signaling pathway, FG offers a multi-faceted approach to neuroprotection. While these findings in mice are promising, future clinical trials are necessary to determine the efficacy and optimal dosing for human patients suffering from stress-related memory loss.
Summary updated